FDC announced that Company's sterile ophthalmic manufacturing facility located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra had recently undergone following inspections:-
1. PIC/S Malaysia inspection started from 07 August 2018 and was completed successfully on 10 August2018. The inspection was carried out with respect to the oral liquids and oral powders for the ROW markets and;
2.
During the above PIC/S inspection, there was also an un-announced inspection by the US FDA which started on 08 August 18. Further, there was a civil unrest on 09 August 2018. However, the US FDA inspection continued from the next day i.e 10 August 2018 and was completed on 16 August 2018.
The US FDA inspection was carried out in relation to the Ophthalmics products being exported to USA market. The US FDA has made 8 observations ( 483's) for which appropriate response shall be submitted by the Company.
However, the Company continues to export its Ophthalmics products to USA market.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)